Found 16 matching trials
Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration PHASE4 To assess the efficacy of intravitreal (IVT) administration of aflibercept ...
Show More Location
Multiple Locations
Learn More & Join Trial
Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept PHASE4 This study is designed to evaluate the safety and efficacy of every 2 week ...
Show More Learn More & Join Trial
Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study PHASE2 The purpose of this study is to assess the safety and efficacy of intravitr...
Show More Location
Moorfields Eye Hospital
Learn More & Join Trial
An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy PHASE4 Polypoidal choroidal neovasculopathy (PCV) is a subtype of wet age related ...
Show More Location
Singapore National Eye Centre
Learn More & Join Trial
Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD) PHASE3 The primary objective is to assess long-term safety and tolerability of Int...
Show More Location
Multiple Locations
Learn More & Join Trial
Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO) PHASE4 This will be a 24 month phase IV, randomised, prospective, multicentre, cli...
Show More Location
Save Sight Institute
Learn More & Join Trial
Intense Treatment Regimen With Intravitreal Aflibercept Injection PHASE1 This study will evaluate the safety and efficacy of intense dosing for a li...
Show More Location
Vitreous Retina Macula Consultants of New York
Learn More & Join Trial
A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration PHASE3 This study will evaluate the effectiveness and safety of a 36-week refill r...
Show More Learn More & Join Trial
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab PHASE4 The purpose of this study is to determine the efficacy of intravitreal afli...
Show More Location
Charlotte Eye Ear Nose and Throat Associates, PA
Learn More & Join Trial
VITAL - Individualising Therapy for Neovascular AMD With Aflibercept PHASE4 The purpose of this study is to assess a new treatment pattern for afliberc...
Show More Location
Moorfields Eye Hospital NHS Foundation Trust
Learn More & Join Trial